Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Jul-19 4:30 PM View:  | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 15,000 | -- | -- | 25% 59.83K to 74.83K | |
| 14-Mar-17 5:57 PM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Mar-17 | Market Purchase | 10,559 | $9.47 | $99,993.70 | 21% 49.27K to 59.83K | (97%) |
| 12-Aug-16 1:19 PM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Conversion | 39,274 | $6.71 | $263,368.00 | 100% 0 to 39.27K | |
| 12-Aug-16 1:19 PM View: | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Purchase | 10,000 | $10.00 | $100,000.00 | 25% 39.27K to 49.27K | |
| 11-Feb-15 7:35 PM View: | Asterias Biotherapeutics, I... (NONE) | 09-Feb-15 | Purchase | 128,205 | $3.90 | $500,000.00 | 32% 400.0K to 528.21K | |
| 16-Jun-14 9:58 PM View: | Asterias Biotherapeutics, I... (NONE) | 12-Jun-14 | Grant | 200,000 | $2.34 | $468,000.00 | 100% 200.0K to 400.0K | |
| 11-Jun-14 9:39 PM View: | Asterias Biotherapeutics, I... (NONE) | 09-Jun-14 | Acquisition (other) | 200,000 | -- | -- | 100% 0 to 200.0K | |
| 06-Jun-13 7:04 PM View: | BioTime Inc. (LCTX) | 04-Jun-13 | Purchase | 120,000 | -- | -- | 1920% 6.25K to 126.25K | |
| 10-Apr-13 9:59 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 08-Apr-13 | Option Exercise | 148,000 | $12.69 | $1,877,680.00 | 142% 104.08K to 252.08K | |
| 10-Apr-13 9:59 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 08-Apr-13 | Market Option Sale | 148,000 | $14.69 | $2,173,990.00 | (59%) 252.08K to 104.08K | 13% |
| 19-Nov-12 7:31 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 08-Nov-12 | Market Purchase | 11,000 | $9.08 | $99,847.00 | 12% 93.08K to 104.08K | 40% |
| 17-May-12 1:23 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 15-May-12 | Acquisition (other) | 2,185 | $9.72 | $21,246.90 | 2% 90.89K to 93.08K | |
| 12-Apr-12 1:09 PM View: | BioTime Inc. (LCTX) | 11-Apr-12 | Market Purchase | 6,250 | $3.98 | $24,850.00 | 100% 0 to 6.25K | (32%) |
| 17-Nov-11 2:31 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 15-Nov-11 | Acquisition (other) | 173 | $9.72 | $1,682.25 | < 1% 90.72K to 90.89K | |
| 04-Aug-11 5:46 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 04-Aug-11 | Market Purchase | 25,000 | $8.98 | $224,450.00 | 38% 65.72K to 90.72K | 42% |
| 01-Jul-11 11:47 AM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 30-Jun-11 | Grant | 21,000 | $11.89 | $249,690.00 | 47% 44.72K to 65.72K | 7% |
| 01-Jun-11 1:30 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 27-May-11 | Grant | 20,000 | $12.34 | $246,800.00 | 81% 24.72K to 44.72K | 3% |
| 17-May-11 4:00 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 16-May-11 | Acquisition (other) | 2,500 | $7.71 | $19,273.80 | 11% 22.22K to 24.72K | |
| 22-Mar-11 5:36 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 02-Feb-11 | Grant | 20,000 | $12.34 | $246,800.00 | 909% 2.2K to 22.2K | 3% |
| 16-Nov-10 5:23 PM View: | Optimer Pharmaceuticals, Inc. (OPTR) | 15-Nov-10 | Acquisition (other) | 2,220 | $7.71 | $17,115.10 | 100% 0 to 2.22K |